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The infant gut microbiome is rapidly colonized by bacteria from the environment after birth, and this gut
ecosystem can facilitate expansion of potential pathogens. Human milk shapes the infant gut microbiome and
has evolved to foster the growth of speciﬁc bacteria. Breastfed infants fed the coevolved infant gut symbiont
Biﬁdobacterium longum subsp. infantis EVC001 had signiﬁcant modiﬁcations to their gut metagenome, including a
decreased number of virulence factor genes.

Virulence factors (VFs) enable bacterial survival and infection in the
host [1] and exhibit a broad spectrum of functions that are indispensable for microbes to achieve colonization, evade the host immune
system and obtain nutrients from the host [2,3]. The advancement of
molecular techniques, particularly metagenomics, has allowed extensive characterization of the VF mechanisms, thus enabling a deeper
understanding of bacterial pathogenesis [2].
Neonates are particularly susceptible to microbial infections since
the infant gut has low microbiome stability and colonization resistance
[4]. In this environment, microbes with VFs can easily establish persistent reservoirs and colonize newborn infants [5]. A rising global incidence of bacteria resistant to several classes of antibiotics, limits effective therapies [6,7], and infections are a leading cause of death in
infant intensive care units [8].
Recent studies have shown how commensal bacteria play a key role
in the evolution and dissemination of VFs, even if they do not directly
express virulence genes [9,10]. There are limited ways by which VFs
and the organisms that harbor them can be restricted without the use of
antibiotics. In a recent clinical trial, we demonstrated how a singlestrain probiotic containing Biﬁdobacterium longum subsp. infantis
EVC001 (B. infantis EVC001) fed to breastfed infants changed the gut
microbiome composition to improve its stability and function [11].
In the present study, we extended our ﬁndings from our previous
clinical trial [11] using shotgun metagenomic sequencing to examine
whether colonization by B. infantis EVC001 signiﬁcantly reduces the
abundance of potential pathogens, and their VFs, in the healthy
breastfed-infant gut microbiome. Shotgun metagenome sequencing was
performed on 60 fecal samples collected from infants at day 21 postnatal. The mothers of 29 breastfed infants were provided lactation
⁎

support, and the infants were fed B. infantis EVC001 daily (EVC001-fed)
from day 7 postnatal. Another 31 mothers received only lactation
support and their infants were not fed B. infantis EVC001 (controls). B.
infantis is a well-characterized organism for which there is extensive
evidence of evolutionary adaptation to the breastfed infant gut [12,13].
However, the infant gut microbiome in resource-rich countries has
experienced a progressive loss of B. infantis, likely due to high rates of
Cesarean section delivery, formula feeding and antibiotics usage over
the last three generations [14].
Metagenomic analysis using clade-speciﬁc marker genes to unambiguously assign reads to functional genes conﬁrmed our previous
16S
rRNA-based
analysis
[15]
(Supplementary
Methods,
Supplementary Table 1). Particularly, feeding B. infantis EVC001 increased Biﬁdobacteriaceae abundance in feces of breastfed infants,
whereas no B. infantis was detected among control samples. After two
weeks of supplementation, Biﬁdobacteriaceae was signiﬁcantly increased (p = 7.18E-07), whereas Enterobacteriaceae (p = 0.0001) and
Clostridiaceae (p = 0.007) families were signiﬁcantly decreased
(Fig. 1A). To proﬁle the VF gene composition in samples, we used a
non-redundant database obtained by merging three well-known VF
gene databases (Supplementary Methods). A total of 2,832 VF genes
were identiﬁed in controls, representing nearly twice the number of VF
genes identiﬁed in EVC001-fed infant samples (Supplementary
Table 2), which contained signiﬁcantly fewer VF genes (p = 0.0001).
On average, EVC001-fed infant samples had an 85% lower relative
abundance of VF genes in the overall metagenome than control samples
(Fig. 1B).
Hierarchal clustering based on the overall abundance of VF gene
proﬁles revealed a marked separation of the individual samples based
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Fig. 1. A) Average relative abundance of top 10 bacterial families identiﬁed within the EVC001-fed and control groups. B) Average relative abundance of virulence
factors in the entire metagenomes. (p < 0.0001, Mann–Whitney test).

understanding [19].
Although ideal for functional classiﬁcation, VF databases are usually
built with genes identiﬁed in model organisms, thus limiting taxonomic
classiﬁcation. To infer the proper taxonomic assignment of bacteria
contributing to the identiﬁed VFs, we performed individual metagenome assemblies of ﬁve representative samples with the most
abundant and diverse VF gene proﬁles (Supplemental methods). Assembled metagenomes were converted into local databases used to retrieve taxonomic information coupling previously identiﬁed cladespeciﬁc VFs amino acids sequences. Higher levels of Biﬁdobacteriaceae
(i.e., B. infantis) were associated with a lower abundance of VFs,
whereas higher abundance of Enterobacteriaceae (e.g., Escherichia coli,
Klebsiella), Clostridiaceae (e.g., Clostridium), Pasteurellaceae (e.g., Haemophilus), Staphylococcaceae and Streptococcaceae families, as well as
diﬀerent potential pathogens belonging to the Proteobacteria and Firmicutes phyla, were related to a higher abundance of VFs (Fig. 2C).
Multivariate linear modeling identiﬁed associations between supplementation status and global relative abundance of bacterial species.
Particularly, Haemophilus parainﬂuenzae, Escherichia coli and

on supplementation status (Fig. 2A). This suggested similarities in VF
type and respective abundances in samples within the same treatment
group, with the majority of those in the EVC001-fed group clustering
with the lower VF gene abundance (Fig. 2A). Furthermore, 146 individual VF genes were lower in the EVC001 group (FDR-p < 0.05).
These genes were mapped to the corresponding KEGG orthologs and
pathways (Fig. 2B). Contextually, many of the gene functions in the
database identiﬁed in samples from EVC001-fed infants as virulence
factors are housekeeping genes that are necessary but not suﬃcient, or
are repurposed from their known housekeeping function, for infection
by pathogenic bacteria [16].
Conserved among the genes for many of the potentially pathogenic
organisms identiﬁed were those for glutathione reductases, arginine Nsuccinyltransferases, stress response regulators (Hsp90, OmpR/EnvZ,
rpoS), Fe(III) and Zn permeases, and ﬂagellar proteins (FliN/FliY)
(Supplementary Table 3). These gene functions are all associated with
response to stress. Host inﬂammation creates an environment that favor
certain taxa who thrive under diﬀerentially oxidative states [17,18],
and a picture of inﬂammation and dysbiosis is emerging based on this
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Fig. 2. A. Heatmap showing virulence factor (VF) abundance across samples in Reads Per Kilobase per Million mapped reads (RPKM). Samples were hierarchically
clustered based on similar VF proﬁles and colored by treatment, with the p-value bar highlighting only signiﬁcant VFs (p < 0.05; Kruskal–Wallis with FDR
correction). B. Abundance among treatments (RPKM) of most signiﬁcant VF (p < 0.05) mapped to 15 KEGG orthologs and 8 KEGG pathways. Higher frequencies are
associated with pathway completeness based on gene presence. C. Relative abundance of bacterial families identiﬁed across samples. “Others” refers to several
bacterial families for which individual relative abundance was lower than 1%. D. Diﬀerences in the gut microbiome composition at the species level between the
EVC001-fed and control groups. Bar plot of γ-coeﬃcients from multivariate association with linear models (MaAsLin) statistical analysis assessing associations
between microbial species and supplementation status. Positive (teal bars) and negative (grey bar) coeﬃcient values represent taxa enriched in the EVC001-fed group
and the control group, respectively. Q-values are FDR-adjusted p-values as computed by MaAsLin.

performed in accordance with relevant guidelines and regulations.

Streptococcus mitis were signiﬁcantly higher in controls. Biﬁdobacterium
longum was signiﬁcantly increased in the EVC001-supplemented group
(Fig. 2, D).
This is the ﬁrst study using shotgun metagenomic sequencing to
report a direct eﬀect of VF gene reduction in the infant gut bacterial
community in response to colonization by a probiotic organism.
Colonization of breastfed infants with B. infantis EVC001 may oﬀer an
attractive approach to reduce the number of VFs and the relative
abundance of potential pathogenic gut bacteria that harbor them.
Future work will be needed to determine whether colonization by B.
infantis EVC001 relates to increased resilience in the face of pathogen
challenges.

Consent for publication
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